Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'INDUCED PARKINSONISM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 224 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bezard, E; Brotchie, JM; Gross, CE
      Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies

      NATURE REVIEWS NEUROSCIENCE
    2. Beal, MF
      Experimental models of Parkinson's disease

      NATURE REVIEWS NEUROSCIENCE
    3. Farver, DK; Khan, MH
      Zolpidem for antipsychatic-induced parkinsonism

      ANNALS OF PHARMACOTHERAPY
    4. Cumming, P; Munk, OL; Doudet, D
      Loss of metabolites from monkey striatum during PET with FDOPA

      SYNAPSE
    5. Colcher, A; Simuni, T
      Other Parkinson syndromes

      NEUROLOGIC CLINICS
    6. Rothblat, DS; Schroeder, JA; Schneider, JS
      Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: Potential contributors to spontaneous recovery from experimental Parkinsonism

      JOURNAL OF NEUROSCIENCE RESEARCH
    7. Kupsch, A; Sautter, J; Gotz, ME; Breithaupt, W; Schwarz, J; Youdim, MBH; Riederer, P; Gerlach, M; Oertel, WH
      Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline

      JOURNAL OF NEURAL TRANSMISSION
    8. Hassin-Baer, S; Sirota, P; Korczyn, AD; Treves, TA; Epstein, B; Shabtai, H; Martin, T; Litvinjuk, Y; Giladi, N
      Clinical characteristics of neuroleptic-induced parkinsonism

      JOURNAL OF NEURAL TRANSMISSION
    9. Sethi, KD
      Movement disorders induced by dopamine blocking agents

      SEMINARS IN NEUROLOGY
    10. Bezard, E; Dovero, S; Prunier, C; Ravenscroft, P; Chalon, S; Guilloteau, D; Crossman, AR; Bioulac, B; Brotchie, JM; Gross, CE
      Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease

      JOURNAL OF NEUROSCIENCE
    11. Gordon, CR; Gonen, A; Nachum, Z; Doweck, I; Spitzer, O; Shupak, A
      The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance

      JOURNAL OF PSYCHOPHARMACOLOGY
    12. Hurley, MJ; Mash, DC; Jenner, P
      Dopamine D-1 receptor expression in human basal ganglia and changes in Parkinson's disease

      MOLECULAR BRAIN RESEARCH
    13. Deuschl, G; Raethjen, J; Lindemann, M; Krack, P
      The pathophysiology of tremor

      MUSCLE & NERVE
    14. Olanow, CW; Watts, RL; Koller, WC
      An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines

      NEUROLOGY
    15. Levy, R; Dostrovsky, JO; Lang, AE; Sime, E; Hutchison, WD; Lozano, AM
      Effects of apomorphine on subthalamic nucleus and globus pallidus internusneurons in patients with Parkinson's disease

      JOURNAL OF NEUROPHYSIOLOGY
    16. Wichmann, T; Kliem, MA; DeLong, MR
      Antiparkinsonian and behavioral effects of inactivation of the substantia nigra pars reticulata in hemiparkinsonian primates

      EXPERIMENTAL NEUROLOGY
    17. Guridi, J; Obeso, JA
      The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma

      BRAIN
    18. Berg, D; Jabs, B; Merschdorf, U; Beckmann, H; Becker, G
      Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy

      BIOLOGICAL PSYCHIATRY
    19. Caligiuri, MP; Jeste, DV; Lacro, JP
      Antipsychotic-induced movement disorders in the elderly - Epidemiology andtreatment recommendations

      DRUGS & AGING
    20. Howell, LL; Byrd, LD; McDonough, AM; Iuvone, PM; Bakay, RAE
      Behavioral evaluation of hemiparkinsonian MPTP monkeys following dopamine pharmacological manipulation and adrenal co-graft transplantation

      CELL TRANSPLANTATION
    21. Benazzouz, A; Piallat, B; Ni, ZG; Koudsie, A; Pollak, P; Benabid, AL
      Implication of the subthalamic nucleus in the pathophysiology and pathogenesis of Parkinson's disease

      CELL TRANSPLANTATION
    22. Mandir, AS; Vaughan, C
      Pathophysiology of Parkinson's disease

      INTERNATIONAL REVIEW OF PSYCHIATRY
    23. Combs, DR; Advokat, C
      Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia

      SCHIZOPHRENIA RESEARCH
    24. Breese, CR; Lee, MJ; Adams, CE; Sullivan, B; Logel, J; Gillen, KM; Marks, MJ; Collins, AC; Leonard, S
      Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    25. Doudet, DJ; Holden, JE; Jivan, S; McGeer, E; Wyatt, RJ
      In vivo PET studies of the dopamine D2 receptors in rhesus monkeys with long-term MPTP-induced parkinsonism

      SYNAPSE
    26. Pope-Coleman, K; Tinker, JP; Schneider, JS
      Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergicmarkers in the striatum of parkinsonian monkeys

      SYNAPSE
    27. Jinnah, HA; Sepkuty, JP; Ho, T; Yitta, S; Drew, T; Rothstein, JD; Hess, EJ
      Calcium channel agonists and dystonia in the mouse

      MOVEMENT DISORDERS
    28. Albin, RL
      Basal ganglia neurotoxins

      NEUROLOGIC CLINICS
    29. Matsuo, H; Matsui, A; Nasu, R; Takanaga, H; Inoue, N; Hattori, F; Ohtani, W; Sawada, Y
      Propiverine-induced Parkinsonism: A case report and a pharmacokinetic/pharmacodynamic study in mice

      PHARMACEUTICAL RESEARCH
    30. Filion, M
      Physiologic basis of dyskinesia

      ANNALS OF NEUROLOGY
    31. Calon, F; Grondin, R; Morissette, M; Goulet, M; Blanchet, PJ; Di Paolo, T; Bedard, PJ
      Molecular basis of levodopa-induced dyskinesias

      ANNALS OF NEUROLOGY
    32. Vitek, JL; Giroux, M
      Physiology of hypokinetic and hyperkinetic movement disorders: Model for dyskinesia

      ANNALS OF NEUROLOGY
    33. Lozano, AM; Lang, AE; Levy, R; Hutchison, W; Dostrovsky, J
      Neuronal recordings in Parkinson's disease Patients with dyskinesias induced by apomorphine

      ANNALS OF NEUROLOGY
    34. Olanow, CW; Obeso, JA
      Preventing levodopa-induced dyskinesias

      ANNALS OF NEUROLOGY
    35. Marini, AM; Nowak, TS
      Metabolic effects of 1-methyl-4-phenylpyridinium (MPP+) in primary neuron cultures

      JOURNAL OF NEUROSCIENCE RESEARCH
    36. Chadha, A; Dawson, LG; Jenner, PG; Duty, S
      Effect of unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway on GABA(A) receptor subunit gene expression in the rodent basal ganglia and thalamus

      NEUROSCIENCE
    37. Ochi, M; Koga, K; Kurokawa, M; Kase, H; Nakamura, J; Kuwana, Y
      Systemic administration of adenosine A(2A) receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: A microdialysis study

      NEUROSCIENCE
    38. Raz, A; Vaadia, E; Bergman, H
      Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism

      JOURNAL OF NEUROSCIENCE
    39. Nash, JE; Brotchie, JM
      A common signaling pathway for striatal NMDA and adenosine A(2a) receptors: Implications for the treatment of Parkinson's disease

      JOURNAL OF NEUROSCIENCE
    40. Marsalek, M
      Tardive drug-induced extrapyramidal syndromes

      PHARMACOPSYCHIATRY
    41. Obeso, JA; Rodriguez-Oroz, MC; Rodriguez, M; Lanciego, JL; Artieda, J; Gonzalo, N; Olanow, CW
      Pathophysiology of the basal ganglia in Parkinson's disease

      TRENDS IN NEUROSCIENCES
    42. Olanow, CW; Schapira, AHV; Rascol, O
      Continuous dopamine-receptor stimulation in early Parkinson's disease

      TRENDS IN NEUROSCIENCES
    43. McGrew, DM; Irwin, I; Langston, JW
      Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice

      NEUROTOXICOLOGY
    44. Hikosaka, O; Takikawa, Y; Kawagoe, R
      Role of the basal ganglia in the control of purposive saccadic eye movements

      PHYSIOLOGICAL REVIEWS
    45. Goulet, M; Madras, BK
      D-1 dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    46. Crossman, AR
      Functional anatomy of movement disorders

      JOURNAL OF ANATOMY
    47. Lee, HS; Park, CW; Kim, YS
      MPP+ increases the vulnerability to oxidative stress rather than directly mediating oxidative damage in human neuroblastoma cells

      EXPERIMENTAL NEUROLOGY
    48. Jellinger, KA
      The role of iron in neurodegeneration - Prospects for pharmacotherapy of Parkinson's disease

      DRUGS & AGING
    49. Yu, J; Castagnoli, N
      Synthesis and MAO-B substrate properties of 1-methyl-4-heteroaryl-1,2,3,6-tetrahydropyridines

      BIOORGANIC & MEDICINAL CHEMISTRY
    50. Yu, JA; Castagnoli, N
      Synthesis and monoamine oxidase B substrate properties of 1-methyl-4-heteroaryl-1,2,3,6-tetrahydropyridines

      BIOORGANIC & MEDICINAL CHEMISTRY
    51. Bezard, E; Boraud, T; Bioulac, B; Gross, CE
      Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms

      EUROPEAN JOURNAL OF NEUROSCIENCE
    52. Stefani, A; Spadoni, F; Giacomini, P; Lavaroni, F; Bernardi, G
      The modulation of calcium current by GABA metabotropic receptors in a sub-population of pallidal neurons

      EUROPEAN JOURNAL OF NEUROSCIENCE
    53. Kupsch, A; Earl, C
      Neurosurgical interventions in the treatment of idiopathic Parkinson disease: neurostimulation and neural implantation

      JOURNAL OF MOLECULAR MEDICINE-JMM
    54. Bahnmaier, AH; Woesle, B; Thomas, H
      Stereospecific N-methylation of the tetrahydroisoquinoline alkaloids isosalsoline and salsolidine by amine N-methyltransferase A from bovine liver

      CHIRALITY
    55. Aziz, SJ; Campbell-Taylor, I
      Neglect and abuse associated with undernutrition in long-term care in North America: Causes and solutions

      JOURNAL OF ELDER ABUSE & NEGLECT
    56. Wilms, H; Sievers, J; Deuschl, G
      Animal models of tremor

      MOVEMENT DISORDERS
    57. Brownell, AL; Jenkins, BG; Isacson, O
      Dopamine imaging markers and predictive mathematical models for progressive degeneration in Parkinson's disease

      BIOMEDICINE & PHARMACOTHERAPY
    58. Duan, WZ; Zhang, ZM; Gash, DM; Mattson, MP
      Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease

      ANNALS OF NEUROLOGY
    59. Vitek, JL; Chockkan, V; Zhang, JY; Kaneoke, Y; Evatt, M; DeLong, MR; Triche, S; Mewes, K; Hashimoto, T; Bakay, RAE
      Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus

      ANNALS OF NEUROLOGY
    60. Tison, F; Lecaroz, J; Letenneur, L; Dartigues, JF
      Parkinsonism and exposure to neuroleptic drugs in elderly people living ininstitutions

      CLINICAL NEUROPHARMACOLOGY
    61. Spencer, PS
      Food toxins, AMPA receptors, and motor neuron diseases

      DRUG METABOLISM REVIEWS
    62. Gross, CE; Boraud, T; Guehl, D; Bioulac, B; Bezard, E
      From experimentation to the surgical treatment of Parkinson's disease: Prelude or suite in basal ganglia research?

      PROGRESS IN NEUROBIOLOGY
    63. Rapoport, A; Stein, D; Schwartz, M; Levin, J; Stier, S; Elizur, A; Rabey, JM
      A trial of L-Deprenyl for the treatment of neuroleptic-induced parkinsonism

      JOURNAL OF NEURAL TRANSMISSION
    64. Akbostanci, MC; Atbasoglu, EC; Balaban, H
      Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution

      ACTA NEUROLOGICA BELGICA
    65. Doudet, DJ; Chan, GLY; Jivan, S; DeJesus, OT; McGeer, EG; English, C; Ruth, TJ; Holden, JE
      Evaluation of dopaminergic presynaptic integrity: 6-[F-18]fluoro-L-dopa versus 6-[F-18]fluoro-L-m-tyrosine

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    66. Stanford, IM; Cooper, AJ
      Presynaptic mu and delta opioid receptor modulation of GABA(A) IPSCs in the rat globus pallidus in vitro

      JOURNAL OF NEUROSCIENCE
    67. Mamo, DC; Sweet, RA; Keshavan, MS
      Managing antipsychotic-induced parkinsonism

      DRUG SAFETY
    68. Bhatt, MH; Elias, MA; Mankodi, AK
      Acute and reversible parkinsonism due to organophosphate pesticide intoxication - Five cases

      NEUROLOGY
    69. Adler, CH
      Differential diagnosis of Parkinson's disease

      MEDICAL CLINICS OF NORTH AMERICA
    70. Tolwani, RJ; Jakowec, MW; Petzinger, GM; Green, S; Waggie, K
      Experimental models of Parkinson's disease: Insights from many models

      LABORATORY ANIMAL SCIENCE
    71. Khudados, E; Cody, FWJ; O'Boyle, DJ
      Proprioceptive regulation of voluntary ankle movements, demonstrated usingmuscle vibration, is impaired by Parkinson's disease

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    72. LOZANO AM; LANG AE
      PALLIDOTOMY FOR PARKINSONS-DISEASE

      Neurosurgery clinics of North America
    73. MARTIMASSO JF; POZA JJ
      CINNARIZINE-INDUCED PARKINSONISM - 10 YEARS LATER

      Movement disorders
    74. OVSIEW F; MEADOR KJ; SETHI K
      VERAPAMIL FOR SEVERE HYPERKINETIC MOVEMENT-DISORDERS

      Movement disorders
    75. DIEDERICH NJ; GOETZ CG
      DRUG-INDUCED MOVEMENT-DISORDERS

      Neurologic clinics
    76. Usuki, E; Van der Schyf, CJ; Castagnoli, N
      Metabolism of haloperidol and its tetrahydropyridine dehydration product HPTP

      DRUG METABOLISM REVIEWS
    77. BEZARD E; BORAUD T; IMBERT C; DOVERO S; BIOULAC B; GROSS CE
      TOWARDS A DYNAMIC APPROACH OF EXPERIMENTAL PARKINSONISM

      Progress in neuro-psychopharmacology & biological psychiatry
    78. MASUR H; ALTHOFF S; ERIM Y; OBERWITTLER C; HORNUNG WP
      POSTEXCITATORY INHIBITION AFTER TRANSCRANIAL MAGNETIC STIMULATION OF THE MOTOR CORTEX IN PATIENTS WITH DRUG-INDUCED PARKINSONISM AND IN HEALTHY-INDIVIDUALS

      International clinical psychopharmacology
    79. UBEDA JV
      NULL HYPOTHESIS OF HUSBAND-WIFE CONCORDANCE OF PARKINSONS-DISEASE IN 1,000 MARRIED-COUPLES OVER AGE 50 IN SPAIN

      Neuroepidemiology
    80. BERGMAN H; FEINGOLD A; NINI A; RAZ A; SLOVIN H; ABELES M; VAADIA E
      PHYSIOLOGICAL-ASPECTS OF INFORMATION-PROCESSING IN THE BASAL GANGLIA OF NORMAL AND PARKINSONIAN PRIMATES

      Trends in neurosciences
    81. HARAGUCHI K; ITO K; KOTAKI H; SAWADA Y; IGA T
      CATALEPSY INDUCED BY CALCIUM-CHANNEL BLOCKERS IN MICE

      Biopharmaceutics & drug disposition
    82. HAMONVILCOT B; CHAUFOUR S; DESCHAMPS C; CANAL M; ZIELENIUK I; AHTOY P; CHRETIEN P; ROSENZWEIG P; NASR A; PIETTE F
      SAFETY AND PHARMACOKINETICS OF A SINGLE ORAL DOSE OF AMISULPRIDE IN HEALTHY ELDERLY VOLUNTEERS

      European Journal of Clinical Pharmacology
    83. PFANN KD; PENN RD; SHANNON KM; CORCOS DM
      PALLIDOTOMY AND BRADYKINESIA - IMPLICATIONS FOR BASAL GANGLIA FUNCTION

      Neurology
    84. JESTE DV; LOHR JB; EASTHAM JH; ROCKWELL E; CALIGIURI MP
      ADVERSE NEUROBIOLOGICAL EFFECTS OF LONG-TERM USE OF NEUROLEPTICS - HUMAN AND ANIMAL STUDIES

      Journal of Psychiatric Research
    85. MATSUI A; MATSUO H; TAKANAGA H; SASAKI S; MAEDA M; SAWADA Y
      PREDICTION OF CATALEPSIES INDUCED BY AMIODARONE, APRINDINE AND PROCAINE - SIMILARITY IN CONFORMATION OF DIETHYLAMINOETHYL SIDE-CHAIN

      The Journal of pharmacology and experimental therapeutics
    86. BORAUD T; BEZARD E; GUEHL D; BIOULAC B; GROSS C
      EFFECTS OF L-DOPA ON NEURONAL-ACTIVITY OF THE GLOBUS-PALLIDUS EXTERNALIS (GPE) AND GLOBUS-PALLIDUS INTERNALIS (GPI) IN THE MPTP-TREATED MONKEY

      Brain research
    87. ROTHBLAT DS; SCHNEIDER JS
      THE EFFECTS OF L-DEPRENYL TREATMENT, ALONE AND COMBINED WITH GM1 GANGLIOSIDE, ON STRIATAL DOPAMINE CONTENT AND SUBSTANTIA-NIGRA PARS COMPACTA NEURONS

      Brain research
    88. Yoshihara, S; Ohta, S
      Involvement of hepatic aldehyde oxidase in conversion of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) to 1-Methyl-4-phenyl-5,6-dihydro-2-pyridone

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    89. DALACK GW; HEALY DJ; MEADORWOODRUFF JH
      NICOTINE DEPENDENCE IN SCHIZOPHRENIA - CLINICAL PHENOMENA AND LABORATORY FINDINGS

      The American journal of psychiatry
    90. JENNER PG
      IS STIMULATION OF D-1 AND D-2 DOPAMINE-RECEPTORS IMPORTANT FOR OPTIMAL MOTOR FUNCTIONING IN PARKINSONS-DISEASE

      European journal of neurology
    91. POMERLEAU CS
      COFACTORS FOR SMOKING AND EVOLUTIONARY PSYCHOBIOLOGY

      Addiction
    92. SCHAPIRA AHV
      PATHOGENESIS OF PARKINSONS-DISEASE

      Bailliere's clinical neurology
    93. TISON F
      OTHER CAUSES OF PARKINSONISM

      Bailliere's clinical neurology
    94. EBERLING JL; BANKIEWICZ KS; JORDAN S; VANBROCKLIN HF; JAGUST WJ
      PET STUDIES OF FUNCTIONAL COMPENSATION IN A PRIMATE MODEL OF PARKINSONS-DISEASE

      NeuroReport
    95. DEBOCK GH; EELHART J; VANMARWIJK HWJ; TROMP TP; SPRINGER MP
      A POSTMARKETING STUDY OF FLUNARIZINE IN MIGRAINE AND VERTIGO

      Pharmacy world & science
    96. MURER MG; RIQUELME LA; TSENG KY; PAZO JH
      SUBSTANTIA-NIGRA PARS RETICULATA SINGLE-UNIT ACTIVITY IN NORMAL AND 60HDA-LESIONED RATS - EFFECTS OF INTRASTRIATAL APOMORPHINE AND SUBTHALAMIC LESIONS

      Synapse
    97. GILADI N; KAO R; FAHN S
      FREEZING PHENOMENON IN PATIENTS WITH PARKINSONIAN SYNDROMES

      Movement disorders
    98. RIOUX L; FROHNA PA; JOYCE JN; SCHNEIDER JS
      THE EFFECTS OF CHRONIC LEVODOPA TREATMENT ON PRESYNAPTIC AND POSTSYNAPTIC MARKERS OF DOPAMINERGIC FUNCTION IN STRIATUM OF PARKINSONIAN MONKEYS

      Movement disorders
    99. HUTCHISON WD; LEVY R; DOSTROVSKY JO; LOZANO AM; LANG AE
      EFFECTS OF APOMORPHINE ON GLOBUS-PALLIDUS NEURONS IN PARKINSONIAN-PATIENTS

      Annals of neurology
    100. SUAREZ JI; METMAN LV; REICH SG; DOUGHERTY PM; HALLETT M; LENZ FA
      PALLIDOTOMY FOR HEMIBALLISMUS - EFFICACY AND CHARACTERISTICS OF NEURONAL-ACTIVITY

      Annals of neurology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 06:32:07